Tülin BAYRAK, AHMET KARATAŞ, Ahmet BAYRAK, Ebru ÇANAKCI

Oxidant and antioxidant mechanisms in chronic kidney disease

Aim: The objective of this study was to evaluate the correlation of inflammation, oxidant and antioxidant biomarkers with the stages of CKD.It is well known that inflammation has an important role in CKD. While PON-1 and PAF-AH are biomarkers with antioxidant characteristics, MDA is an oxidant biomarker.Material and Methods: The participants were divided into 3 groups. Control (n=37) group, non-hemodialysis chronic kidney disease (non-HD CKD) group and hemodialysis group (n=40) . One hudred twenty-one participants were included in this cross-sectional and observational study. Serum PON-1, PAF-AH, MDA levels were measured.Results: There was a significant difference between the groups regarding the median MDRD values (p

PDF

___

1. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-100.
2. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters Kidney Int 2017;92:26-36
3. Mihai S, Codrici E, Popescu ID, et al. Inflammation and chronic kidney disease: current approaches and recent advances, in: Chronic Kidney Disease, Ed:Thomas Rath, Intechopen, Rijeka, Croatia; 2018. pp. 31-51.
4. Henderson LW, Koch KM, Dinarello CA, et al. Hemodialysis hypotension: the interleukin hypothesis. Blood Purifi cation1983;1:3-8.
5. Vaziri ND. Oxidative stress in chronic renal failure: the nature, mechanism and consequences. Semin Nephrol 2004;24:469-73.
6. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002;15:329-37.
7. Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular dis- ease in uremia. Kidney Int 2002;62:1524-38.
8. Imaizumi TA, Stafforini DM, Yamada Y, et al. Platelet - activating factor: A mediator for clinicians. J Intern Med 1995;238:5-20.
9. Camussi G, Salvidio G, Tetta C. Platelet-activating factor in renal disease. Am J Nephrol 1989;9:23-6. 10. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985;64:111-26.
11. Ruperez AI, Gil A, Aguilera CM. Genetics of oxidative stress in obesity. Int J Mol Sci 2014;15:3118-44.
12. Kao MPC, Ang DSC, Pall A, et al. Oxidative stress in renal dysfunction: Mechanisms, clinical sequelae and therapeutic options. Journal of Human Hypertension. 2010; 24:1-8.
13. Panth N, Paudel KR, Parajuli K. Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease. Adv Med 2016;2016:9152732.
14. Papavasiliou EC, Gouva C, Siamopoulos KC, et al. Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin. Kidney Int 2005;68:246-55.
15. Papavasiliou EC, Gouva C, Siamopoulos KC, et al. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin. Nephrol Dial Transplant 2006;21:1270-7.
16. Neelofar K, Arif Z, Arafat MY, et al. A study on correlation between oxidative stress parameters and inflammatory markers in type 2 diabetic patients with kidney dysfunction in north Indian population. J Cell Biochem 2018;27.
17. Ogunleye A, Akinbodewa AA, Adejumo OA, et al. Changes in antioxidant status associated with haemodialysis in chronic kidney disease. Ghana Med J 2018;52:29-33.
18. Kennedy DJ, Tang WH, Fan Y, et al. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease. J Am Heart Assoc. 2013;2:e000104.
19. Abdallah E, El-Shishtawy S, Sherif N, et al. Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients. Int Urol Nephrol 2017;49:329-35.
20. Karatas A, Canakci E, Bektas O, et al. Relationship of epicardial fat tissue thickness with oxidant biomarkers in chronic kidney disease. Bratisl Lek Listy. 2018;119:566-71.